The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.
Briones
M
M
Chiron Technologies, Chiron Corporation, Emeryville, California 94608, USA.
Singh
M
M
Ugozzoli
M
M
Kazzaz
J
J
Klakamp
S
S
Ott
G
G
O'Hagan
D
D
D000818:Animals; D002412:Cations; D000077286:Cetrimonium; D002593:Cetrimonium Compounds / Q000737:chemistry; D004247:DNA / Q000737:chemistry; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015683:Gene Products, gag / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D007074:Immunoglobulin G / Q000096:biosynthesis; D019344:Lactic Acid / Q000737:chemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D008863:Microspheres; D010316:Particle Size; D010957:Plasmids / Q000276:immunology; D011100:Polyglycolic Acid / Q000737:chemistry; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000737:chemistry; D011498:Protein Precursors / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology
D002412:Cations; D002593:Cetrimonium Compounds; D015683:Gene Products, gag; D015699:HIV Envelope Protein gp120; D007074:Immunoglobulin G; D011108:Polymers; D011498:Protein Precursors; D019444:Vaccines, DNA; C059767:p55 gag precursor protein, Human immunodeficiency virus 1; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D004247:DNA; D000077286:Cetrimonium